Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Profound Medical (PROF) Shares Issued (2019 - 2024)

Profound Medical has reported Shares Issued over the past 5 years, most recently at $44000.0 for Q4 2024.

  • For Q4 2024, Shares Issued rose 102.02% year-over-year to $44000.0; the TTM value through Dec 2024 reached $45000.0, down 81.63%, while the annual FY2025 figure was $42.4 million, 94202.22% up from the prior year.
  • Shares Issued for Q4 2024 was $44000.0 at Profound Medical, up from -$22.9 million in the prior quarter.
  • Over five years, Shares Issued peaked at $85.5 million in Q4 2020 and troughed at -$22.9 million in Q3 2024.
  • A 4-year average of $14.4 million and a median of $1.8 million in 2021 define the central range for Shares Issued.
  • Biggest five-year swings in Shares Issued: soared 882.01% in 2020 and later tumbled 106.13% in 2021.
  • Year by year, Shares Issued stood at $85.5 million in 2020, then tumbled by 106.13% to -$5.2 million in 2021, then skyrocketed by 58.47% to -$2.2 million in 2023, then skyrocketed by 102.02% to $44000.0 in 2024.
  • Business Quant data shows Shares Issued for PROF at $44000.0 in Q4 2024, -$22.9 million in Q3 2024, and $22.9 million in Q1 2024.